that will be up to the patent reviewer and the patent lawyer's will need to narrow claims as required. Given Pfizer's expired patent did not include Vardenafil and Spontan is a unique formulation they should pass the novelty test.
This is the view of the company, and no doubt SDS and the patent lawyers advising them.
There is always back and forth with the patent office as the broad claims are knocked back and companies narrow bit by bit. This ensures they get as much as possible.
If you want specific questions answered about the patent, message the CEO on LinkedIn, tell him you're a shareholder and fire away.
- Forums
- ASX - By Stock
- LTP
- Ann: Commercial Update and Regulatory Progress
LTP
ltr pharma limited
Add to My Watchlist
5.36%
!
29.5¢

Ann: Commercial Update and Regulatory Progress, page-357
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $33.02M |
Open | High | Low | Value | Volume |
28.5¢ | 31.0¢ | 28.5¢ | $112.8K | 382.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19244 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 64264 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2003 | 0.295 |
1 | 50000 | 0.290 |
4 | 72460 | 0.285 |
6 | 160000 | 0.280 |
7 | 60293 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 30000 | 1 |
0.320 | 35258 | 3 |
0.325 | 15384 | 1 |
0.330 | 3437 | 1 |
0.350 | 19241 | 1 |
Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |